Switch View
© Globe Newswire
29.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
News Preview
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
News Preview
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to Metoprolol...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
News Preview
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
29.09.2025
ISIN: US03828A1016
Applied Therapeutics Inc
APLT
LISTED
NASDAQ
Applied Therapeutics Provides Update Following Meeting with FDA
News Preview
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company completed a meeting with the U.S. Food and Drug Administration (FDA) to discuss the potential new drug...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.09.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
News Preview
BALA CYNWYD, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced positive 25 mg and 50 mg data from the ongoing long-term open label (OL) study evaluating daily subcutaneous injections of noml...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Miracle CEO Defeats Cancer and Leads Medical AI Innovation at (OTC PINK:MDCE) Medical Care Technologies Inc.
News Preview
MESA, AZ / ACCESS Newswire / September 29, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announces a new era of leadership and innovation under CEO Marshall Perkins, whose extraordinary personal journey is now fueling the company's mission to transform healthcare. In early 2025, Perkins faced a near-fatal battle with advanced bone can...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
News Preview
MannKind appoints Dr. Ajay Ahuja as EVP and Chief Medical Officer...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Adds Ichor Research as New Site for CALMA Phase 2 Alzheimer's Trial
News Preview
POTOMAC, MD / ACCESS Newswire / September 29, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the addition of a new clinical trial site to its ongoing Phase 2 study evaluating IGC-AD1, an investigational drug candidate for treating agitation in Alzheimer's disease. The new site, Ichor Research, located in Syracuse, New York, is led by P...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
News Preview
SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today announced the exercise of certain existing warrants issued in May 202...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
News Preview
Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH, RDHEP, EFDA, CHO.Candid conversations with leading clinicians on the trends shaping today's dental landscape.Episodes launch on September 29 on major...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025
News Preview
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced additional analyses from its pivotal Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP were presented as poster presentations at the ERS Congress 2025 in Amsterdam, The Netherlands.
ERS 2025 Posters...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA05353D2023
Avant Brands Inc.
AVNT
LISTED
TSX
Avant Brands Recognized as One of Canada's Top Growing Companies by The Globe and Mail for Third Consecutive Year
News Preview
KELOWNA, B.C. / ACCESS Newswire / September 29, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced it has been recognized as one of Canada's Top Growing Companies in The Globe and Mail's 2025 Report on Busine...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESSWIRE
29.09.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
News Preview
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunityThe Company plans to complete patient recruitment for SKNJCT-003 before the end of Q4 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US3723032062
Genmab A/S
GMAB
LISTED
NASDAQ
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
News Preview
Genmab A/S (Nasdaq: GMAB) and Merus N.V. (Nasdaq: MRUS) announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company with its late-stage breakthrough therapy asset petosemtamab, which is in Phase 3 development, for USD 97.00 per share...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova gewinnt Schweizer Innovations-Ranking
News Preview
Sonova Holding AG
/ Schlagwort(e): Sonstiges
Sonova gewinnt Schweizer Innovations-Ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Schweiz), 29. September 2025 – Zum zweiten Mal in Folge ist Sonova als Nummer 1 unter den SMI-Unternehmen* im jährlichen Innovationsranking geführt, das von den ......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova wins Swiss innovation ranking
News Preview
Sonova Holding AG
/ Key word(s): Miscellaneous
Sonova wins Swiss innovation ranking
29.09.2025 / 07:00 CET/CEST
Group Media & Investor Release
Stäfa (Switzerland), September 29, 2025 – For the second consecutive year, Sonova is number one among SMI companies* in the annual innovation ranking compiled by business mag......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.09.2025
ISIN: CH1429326825
Siegfried Holding AG
SFZN
LISTED
SIX
DINAMIQS opens cGMP manufacturing facility for viral vectors
News Preview
Siegfried AG
/ Key word(s): Expansion
DINAMIQS opens cGMP manufacturing facility for viral vectors 29.09.2025 / 06:30 CET/CEST
Media Release
Zofingen, September 29, 2025
DINAMIQS, a Siegfried company (SIX: SFZN), today inaugurated its state-of-the-art cGMP manufacturing facility for viral vectors — the first of its kind in Swi......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: US2538252022
Hypha Labs, Inc.
FUNI
LISTED
OTC
Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing
News Preview
LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it has entered an agreement with Automated Technical Services to design and build a commercial-scale Mushroom Accelerator. This scaled-up system will produ...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
EQUASENS : Bilan S1 2025 contrat de liquidité
News Preview
Villers-lès-Nancy, le 29 septembre 2025 - 08h00 (CET)...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA98421R1055
XPhyto Therapeutics Corp.
XPHY
LISTED
CSE
BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization
News Preview
VANCOUVER,BC / ACCESS Newswire / September 29, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to provide an update on its proprietary Cladribine sublingual thin-film drug reformulation program (BNT23...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: AU000000CUV3
Clinuvel Pharmaceuticals Ltd
CUV
LISTED
ASX
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
News Preview
Next generation sustained-release formulations for a variety of peptides Next generation sustained-release formulations for a variety of peptides...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: GB0034330679
Angle plc
AGL
LISTED
AIMX
Angle PLC Announces Presentation of Data on Glioblastoma
News Preview
CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting GUILDFORD, SURREY / ACCESS Newswire / September 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) so...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
News Preview
VANCOUVER, BC / ACCESS Newswire / September 29, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Nucro-Technics Inc. ("Nucro-Technics"), a Toronto-based contract research organization working in collaboration with Onco to conduc...
Themefolio
Profiler
Peergroup
© BusinessWire
28.09.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Palantir Technologies Announces Two-Day Pop-Up Experience in Seoul
News Preview
Palantir Technologies will open a two-day pop-up merchandise store in Seoul's culturally dynamic Seongdong-gu district from October 14-15, marking the company's first dedicated retail experience for its passionate Korean fanbase. The temporary store at 26 Achasan-ro 11ga-gil in Seongdong-gu will showcase six items—five being sold publicly for the...
Themefolio
Profiler
Peergroup
© Newsfile
28.09.2025
ISIN: CA8271242072
Silo Wellness Inc.
SILO
LISTED
CSE
Silo Wellness Submits CSE Listing Statement for Review of Born Defense Proposed Change of Business
News Preview
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - September 28, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo" or the "Company"), to be renamed Born Defense Inc., is pleased to announce that it has submitted its listing statement (the "Listing Statement") with the Canadian Securities Exchange (the "CSE") on September 26, 2025, for review in co...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
News Preview
TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
News Preview
Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDT Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDT...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beh...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
News Preview
...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PACS Group, Inc. - PACS
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US86627R1023
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTK
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-fre...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 2...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - LNTH
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
News Preview
- By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
News Preview
SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), have until Monday, November 10, 2025 t...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
News Preview
NEW YORK and NEW ORLEANS, Sept. 26, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinet...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beh...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR)....
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL).
On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifica...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Danaher Corporation (NYSE: DHR).
On April 25, 2023, the Company disclosed that "[r]evenues decreased 7.0% year-over-year to $7.2 billion, with a 4.0% non-GAAP co...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced the company will hold a conference call and webcast on Monday, September 29 at 8:30 a.m. ET to share topline results from RSVHR, a Phase 2b study evaluating z...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the closing of its previously announced underwritten public offering of 35,937,500 shares of its common stock,...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA).
IF YOU ARE AN INVE...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
News Preview
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET on September 29, 2025, to discuss recently announced updated overall survival and safety data in first-l...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) today announced that, due to the requisite quorum not being present, the annual general and special meeting of shareholders (the “Meeting”) scheduled for September 26, 2025 at 1:00 p.m. Eastern Time via live webcast was convened and then adjourned. The Meeting has...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Cla...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
